Bullish Charts - Plasma Play, FDA Approved Plasma Facilities
ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
BREAKING NEWS TODAY - 07/30/2020
ADMA Biologics shares are trading higher following a report suggesting the company is near receiving emergency use authorization of Convalescent Plasma in COVID-19 patients.
benzinga.com/wiim/20/07/16846115/adma-biologics-shares-are-trading-higher-following-a-report-suggesting-the-company-is-near-receiving
On July 6, 20, ADMA opened a new plasma facility and is awaiting emergency authorization for a second location.
finance.yahoo.com/news/adma-biologics-opens-newest-adma-110010457.html
With the FDA asking for everyone to donate plasma, this stock could rip!
Plasma stocks ripped today and continue to rip.
This company already is up and running one plasma facility.
Game On!
Long
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
BREAKING NEWS TODAY - 07/30/2020
ADMA Biologics shares are trading higher following a report suggesting the company is near receiving emergency use authorization of Convalescent Plasma in COVID-19 patients.
benzinga.com/wiim/20/07/16846115/adma-biologics-shares-are-trading-higher-following-a-report-suggesting-the-company-is-near-receiving
On July 6, 20, ADMA opened a new plasma facility and is awaiting emergency authorization for a second location.
finance.yahoo.com/news/adma-biologics-opens-newest-adma-110010457.html
With the FDA asking for everyone to donate plasma, this stock could rip!
Plasma stocks ripped today and continue to rip.
This company already is up and running one plasma facility.
Game On!
Long
DISCLAIMER
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.